基因表現市場 - 按流程、產品、應用、技術、產能、最終用戶和預測，2024 年 - 2032 年

Gene Expression Market - By Process, Product, Application, Techniques, Capacity, End-user & Forecast, 2024 - 2032

出版日期: 2024年03月01日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於擴大採用下一代定序 (NGS) 技術對 RNA 樣本進行高通量定序以提供全面的轉錄組資料，因此從2024 年到2032 年，基因表現市場規模預計將達到7% 以上的複合年成長率。基因表現分析在臨床研究和診斷中發揮著至關重要的作用，特別是在癌症、傳染病和罕見遺傳性疾病領域。學術機構、研究組織和生物技術公司不斷努力推動基因表現分析的進步，例如獲得尖端技術以及轉化為臨床應用，這將推動市場成長。舉例來說，2023 年 8 月，馬裡蘭大學 (UMD) 發起的一項新研究揭示了支撐基因表現的複雜過程，擴大了醫學應用。

整個產業分為流程、產品、應用、技術、產能、最終用戶和地區。

就流程而言，到 2032 年，樣本採集領域的基因表現市場價值複合年成長率將達到 6.4%。血液樣本經常透過靜脈穿刺用於基因表現分析。透過研究健康和患病組織中的基因表達，研究人員正在確定潛在的藥物標靶來評估候選藥物的功效。為此，用於改善治療結果的個人化醫療方法的不斷發展將促進該細分市場的成長。

在應用方面，預計2024年至2032年，臨床診斷領域的基因表現產業將以7.5%的複合年成長率擴張。從而提供更準確的診斷和治療。該技術還有助於識別預後和預測生物標記，以提供有關疾病進展和某些治療效果的有價值的資訊。

從地區來看，由於個人化醫療的需求不斷增加，預計2024年至2032年亞太地區基因表現市場規模的複合年成長率將達到7.5%。由於慢性病患病率上升，該地區存在多樣化的患者群體，使其成為臨床研究的有吸引力的目的地。據估計，2022年印度醫生與人口的比例為1：834 政府對積極推動和資助基因組學研究的支持不斷升級，將進一步促進該地區產業的成長。

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 12 章：公司簡介

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
GE HealthCare Technologies, Inc.
Illumina, Inc.
Oxford Nanopore Technologies Plc.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Promega Corporation
Qiagen N.V.
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 8370

Gene Expression Market size is poised to depict over 7% CAGR from 2024-2032, on account of the rising adoption of next-generation sequencing (NGS) technologies for high-throughput sequencing of RNA samples to provide comprehensive transcriptomic data. Gene expression analysis is playing a critical role in clinical research and diagnostics, particularly in the fields of cancer, infectious diseases, and rare genetic disorders. Rising efforts by academic institutions, research organizations, and biotech companies for advancements in gene expression analysis like access to cutting-edge technologies, and translation into clinical applications will drive the market growth. To illustrate, in August 2023, a new study initiated by the University of Maryland (UMD) shed light on the intricate processes underpinning gene expression for broadening applications in medicine.

The overall industry is segmented into process, product, application, technique, capacity, end-user, and region.

In terms of process, the gene expression market value from the sample collection segment will witness 6.4% CAGR through 2032. The growth can be ascribed to the intensifying need for providing valuable insights into the activity of genes. Blood samples are frequently used for gene expression analysis by deploying venipuncture. With the study of the expression of genes in healthy and diseased tissues, researchers are identifying potential drug targets to assess the efficacy of candidate drugs. To that end, the rising development of personalized medicine approaches to improve treatment outcomes will add to the segment growth.

With respect to application, the gene expression industry from the clinical diagnostics segment is expected to expand at 7.5% CAGR from 2024 to 2032. By analyzing gene expression patterns, clinicians can identify specific gene signatures associated with different disease subtypes to render more accurate diagnosis and personalized treatment. This technique also helps identify prognostic and predictive biomarkers to provide valuable information about the progression of diseases and the efficacy of certain treatments.

Regionally, the Asia Pacific gene expression market size is expected to observe 7.5% CAGR from 2024 to 2032, due to the increasing demand for personalized medicine. The presence of diverse patient population across the region due to the rising prevalence of chronic diseases makes it an attractive destination for clinical studies. It has been estimated that the doctor-population ratio in India was 1:834 in 2022. The escalating government support for actively promoting and funding genomics research will further contribute to the regional industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advances that enhance gene expression
  - 3.2.1.2 Growing adoption of personalized medicine
  - 3.2.1.3 High investment in genomic research
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of the instruments
  - 3.2.2.2 Lack of skilled labor
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Process, 2018 - 2032 ($ Million)

5.1 Key trends
5.2 Sample collection
5.3 Purification
5.4 cDNA synthesis & conversion
5.5 PCR analysis
5.6 Data analysis & interpretation

Chapter 6 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Million)

6.1 Key trends
6.2 Consumables
- 6.2.1 Reagents
- 6.2.2 DNA chips
6.3 Instruments
- 6.3.1 PCR
- 6.3.2 NGS
- 6.3.3 DNA microarray
- 6.3.4 Other instruments
6.4 Services

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

7.1 Key trends
7.2 Drug discovery & development
7.3 Clinical diagnostics
7.4 Biotech & microbiology
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Technique, 2018 - 2032 ($ Million)

8.1 Key trends
8.2 RNA expression
8.3 Promoter analysis
8.4 Protein expression & posttranslational modification analysis

Chapter 9 Market Estimates and Forecast, By Capacity, 2018 - 2032 ($ Million)

9.1 Key trends
9.2 Low- to mid- plex
9.3 High-plex

Chapter 10 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

10.1 Key trends
10.2 Pharmaceutical and biotechnology companies
10.3 Diagnostic laboratories
10.4 Academic research centers

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

11.1 Key trends, by region
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.4.6 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa